ALFA Finder| Management target | Revenue 67.0% FY28 |
|---|
| Revenue growth | Consolidated revenue up 10% YoY to 264 Cr; record quarterly sales. |
|---|---|
| Margins | EBITDA at 37%; HALS margins expected to improve with higher grades. |
| Demand visibility | Steady demand environment despite geopolitical headwinds and supply chain challenges. |
| Management confidence | Balanced; optimistic on HALS scale-up but cautious on global logistics. |
Growth
Consolidated revenue grew 10% YoY, with HALS now contributing 22% of sales, diversifying away from legacy products.
Outlook
Targeting 300-350 Cr additional revenue from Swiss partnership over 4 years; HALS scaling toward 300 Cr annually.
Risks
Raw material price volatility due to Middle East crisis and shipping vessel non-availability impact margins.
Last quarter's promises, checked
Delivered
- Guided HQ/Catechol stabilization in 1-2 quarters → delivered customer approvals (= BEAT)
- Guided positive EBITDA for subsidiary → delivered 15% EBITDA margin (= BEAT)
- Guided HALS volume momentum → delivered 1,000+ tonnes/quarter (= BEAT)
Partly delivered
- Guided FY27 Capex 80-100 Cr → delivered 100 Cr investment in subsidiary (= PARTIAL)
Missed
- Guided legacy Performance Chemicals volume growth → delivered 6% decline (= MISS)
Earnings Call Transcript filed with BSE, NSE: CLEAN. Summary written with AI assistance from the document.
Clean Science & Technology Ltd: key numbers
- Share price
- ₹714.00
- Market cap
- ₹7,589 Cr
- Revenue (annual)
- ₹956.5 Cr
- Net profit (annual)
- ₹229.7 Cr
- P/E (TTM)
- 32.5×Sector 35.5×
- Promoter holding
- 51.29%+0.00% QoQ
- FII holding
- 13.72%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Clean Science & Technology Ltd
All →Clean Science & Technology Earnings Call Transcript: Key Takeaways
Record consolidated quarter, with HALS revenue doubling YoY. Standalone margins compressed as raw-material inflation could not be passed on to customers.
Clean Science & Technology Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹299 Cr (+22% YoY), PAT ₹56 Cr (+0.5%), EBITDA margin 31.2% (vs 36.4%). HALS-led growth; margins hit by geopolitical headwinds.
Clean Science & Technology Q2 FY27 Results: Net Profit ₹55.7 Cr, Up 0.5% YoY
Clean Science & Technology Ltd reported revenue from operations of ₹299.4 Cr (+22.4% YoY) and net profit of ₹55.7 Cr (+0.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹55.7 Cr · +0.5% YoY
Clean Science & Technology Business Update
Clean Science's subsidiary Clean Fino-Chem completed product trials for advanced HALS grades developed with Geneus Chem AG. Commercial launch of the new range is expected in H2 FY2026-27.
Clean Science & Technology Other Announcement
Clean Science and Technology Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Clean Science & Technology Board Meeting Date
Clean Science and Technology Ltd has scheduled a board meeting for October 31, 2026, to approve unaudited financial results for the quarter and half year ending September 2026.